CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$1.93
+0.15 (+8.43%)
Open$1.86
Previous Close$1.78
Day High$1.98
Day Low$1.80
52W High$29.76
52W Low$17.39
Volume—
Avg Volume799.1K
Market Cap4.98M
P/E Ratio58.95
EPS$0.48
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,630.1% upside
Current
$1.93
$1.93
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 760.8K | 749.0K | 753.7K |
| Net Income | -122,856 | -154,552 | -129,649 |
| Profit Margin | -16.2% | -20.6% | -17.2% |
| EBITDA | -142,343 | -155,667 | -163,320 |
| Free Cash Flow | -180,689 | -141,548 | -126,501 |
| Rev Growth | +19.4% | +1.8% | -1.9% |
| Debt/Equity | 0.23 | 0.17 | 0.21 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |